PR+ breast cancer responds well to hormone therapy, underscoring the need for molecular insight and targeted treatment ...

Triple-positive breast cancer is a type of breast cancer that tests positive for estrogen receptors, progesterone receptors, and high levels of HER2 protein. Some types of breast cancer cells use ...

As genetic and biomarker tests become more common, so do new therapies that target specific tumor types and may lead to ...

No one enjoys a period, and certainly not exercising on one, either. It’s a multiple day event in the calendar (if we’re ...

It would be short-sided, erroneous and dangerous to think ill of mifepristone, which has several important applications,, M.D ...

hypokalemia or QT prolongation – serious adverse events that can arise in patients taking currently approved medications – ...

Corcept Therapeutics (CORT) announced that the FDA filed its New Drug Application (NDA) submission for its proprietary, selective cortisol ...

MR = Mineralocorticoid receptor; PR = Progesterone receptor. The relative binding affinity (%) of the main progestins discussed in this paper for the different steroid receptors is indicated.

Ciara Foskin’s diagnosis came out of the blue. She is part of a small cohort of women under 50 who develop triple-negative ...

HR+/HER2- breast cancer involves tumor cells that test positive for hormone receptors and negative for HER2 proteins. Cancer cells with estrogen or progesterone hormone receptors can grow in response ...